Skip to main content

Peer Review reports

From: Combination of gemcitabine, nab-paclitaxel, and S-1(GAS) as the first-line treatment for patients with locally advanced or advanced pancreatic ductal adenocarcinoma: study protocol for an open-label, single-arm phase I study

Original Submission
28 Mar 2021 Submitted Original manuscript
6 Apr 2021 Author responded Author comments - Chen Chang
Resubmission - Version 2
6 Apr 2021 Submitted Manuscript version 2
26 Apr 2021 Author responded Author comments - Chen Chang
Resubmission - Version 3
26 Apr 2021 Submitted Manuscript version 3
Publishing
29 Apr 2021 Editorially accepted
13 May 2021 Article published 10.1186/s12885-021-08275-9

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us